PDE3A Activators
Phosphodiesterase 3A (PDE3A) activators comprise a group of chemicals with the ability to directly or indirectly modulate the activity of this phosphodiesterase by influencing the cyclic adenosine monophosphate (cAMP)-protein kinase A (PKA) signaling pathway. Forskolin, a diterpene compound, stands out as a direct activator by directly stimulating adenylyl cyclase, leading to increased cAMP levels and subsequent PKA activation. Isoproterenol and epinephrine, both beta-adrenergic receptor agonists, activate adenylyl cyclase, resulting in elevated cAMP levels and PKA activation, thereby influencing cellular processes regulated by PDE3A.
Amrinone, zardaverine, motapizone, and CDP 840, though classified as PDE3 inhibitors, act as indirect activators by preventing cAMP degradation. These chemicals elevate intracellular cAMP levels, leading to PKA activation and modulation of cellular processes regulated by PDE3A. The intricate interplay between these chemicals, the cAMP-PKA pathway, and PDE3A activity unveils a nuanced understanding of their importance as activators. Forskolin, through its direct action on adenylyl cyclase, and the other compounds, by indirectly modulating cAMP levels, collectively highlight the diverse mechanisms through which PDE3A activity can be influenced. This class of PDE3A activators offers a targeted approach for understanding and manipulating the cellular processes regulated by PDE3A, providing a foundation for further exploration in diverse physiological and pathological contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is a diterpene compound that directly activates adenylyl cyclase, increasing intracellular cyclic adenosine monophosphate (cAMP) levels. Elevated cAMP activates protein kinase A (PKA), influencing various cellular processes regulated by PDE3A. Forskolin's direct action on adenylyl cyclase and subsequent modulation of the cAMP-PKA signaling pathway make it a potential activator of PDE3A. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic receptor agonist that activates adenylyl cyclase, leading to increased cAMP production. The rise in intracellular cAMP levels activates PKA, influencing cellular processes regulated by PDE3A. Through its direct stimulation of adenylyl cyclase and subsequent modulation of the cAMP-PKA pathway, isoproterenol can be considered an activator of PDE3A. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine, a hormone and neurotransmitter, acts on adrenergic receptors to activate adenylyl cyclase, resulting in increased cAMP levels. The elevated cAMP activates PKA, influencing cellular processes regulated by PDE3A. By directly stimulating adenylyl cyclase and modulating the cAMP-PKA signaling pathway, epinephrine can be regarded as an activator of PDE3A. | ||||||
Amrinone | 60719-84-8 | sc-207288 | 1 g | $193.00 | ||
Amrinone is a PDE3 inhibitor that indirectly activates PDE3A by preventing cAMP degradation. By inhibiting PDE3A, amrinone increases intracellular cAMP levels, activating PKA and influencing cellular processes regulated by PDE3A. The drug's impact on the cAMP-PKA pathway highlights its role as an indirect activator of PDE3A, providing a targeted approach for modulating the activity of this phosphodiesterase. | ||||||
Zardaverine | 101975-10-4 | sc-201208 sc-201208A | 5 mg 25 mg | $88.00 $379.00 | 1 | |
Zardaverine is a PDE3 inhibitor that indirectly activates PDE3A by preventing the breakdown of cAMP. By inhibiting PDE3A, zardaverine increases intracellular cAMP levels, activating PKA and influencing cellular processes regulated by PDE3A. The drug's impact on the cAMP-PKA pathway highlights its role as an indirect activator of PDE3A, providing a targeted approach for modulating the activity of this phosphodiesterase. | ||||||